<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=601572900419438&amp;ev=PageView&amp;noscript=1">

ABOUT US

About Northway Biotech US

By The Numbers

2014
Established
>90
Clients Worldwide (Both sites)
>160
Completed Projects (Both sites)

Northway Biotech is a flexible biologics CDMO with a facility in the Greater Boston area (Waltham, MA), a world-leading hub in the field of life sciences research and drug development.

Our global teams based in the US and Europe are exceptionally well-versed in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and aseptic fill-finish.

Our state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment and analytical support, as well as a cGMP manufacturing suite with both single-use and stainless steel systems for upstream and downstream process development, formulation and fill-finish of microbial and mammalian cell culture-based products.

We are deeply invested in providing high-quality, world-class CDMO services and long-term partnerships based on our blend of experience and openly collaborative project teams.

 

Management & Operations

Vladas Bumelis}

Prof. Vladas Algirdas Bumelis

CEO, Executive Chairman of the Board & Advisory Board

Prof. Vladas Bumelis is the Founder of Northway Biotech and currently serves as Chairman of the company’s Board and Advisory Board.  With extensive experience in the pharmaceutical and biotech industries, he previously held key positions such as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for Biofa and Biotechna, and served as Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania.

Prof. Bumelis is the author of 157 scientific publications and 32 inventions. Notable accolades include being named CEO of the year in Lithuania in 2012 and receiving the Lithuanian Science Prize in 2004 for his pioneering work in the development and production of recombinant proteins. In 2020, he was honored with the Officer's Cross Award of the Order "For Merit to Lithuania."  Prof. Bumelis holds a Ph.D. and MSc in Chemistry, along with a Ph.D. in Biotechnology from Vilnius University. 

Vladas has a Ph.D. in chemistry, as well as a Ph.D. in biotechnology from Vilnius University, Lithuania.

Business Development Team

 

Detra Glinatsis}

Detra Glinatsis

Vice President, Business Development

 

Detra Glinatsis has over 20 years of sales experience in the pharmaceutical, biotech and contract manufacturing industries.  Her passion, creativity, and commitment to satisfy customer needs have led to a remarkable reputation in the industry. Prior to joining Northway, Detra has served as a Senior Director of Business Development at AGC Biologics, Rentschler BioPharma, and Gallus Biopharmaceuticals.  In these roles, her efforts spearheading business development and client relationship management generated significant new business growth.  Detra has also served in business and commercial development positions at Avecia Biologics, InVentiv Health, and Sartorius.  Detra holds a bachelor’s in biology from the University of Akron, USA.

Untitled design (25)}

Nick Maragos

Vice President, Business Development

Nick Maragos holds a BSc in Biology from The University of Akron as well as a Graduate Research Associate from The Ohio State University. He has over 30 years of Sales and Marketing experience coming from medical and pharmaceutical companies. Nick has in the past worked for Celonic, Rentschler Biopharma where he was responsible for Business Development both in Europe and the USA.